Pharmacy
http://ouh.dk/wm474806
Lisbeth Muurholm
Phone: +45 23 63 17 92
Mail: lisbeth.muurholm@rsyd.dk
Hanne Kiehn
Phone: +45 23 63 17 80
Mail: hanne.kiehn@rsyd.dk
Jess Brink
Phone: +45 23 63 17 99
Mail: jess.brink@rsyd.dk
Mia Lolk Lund
Phone: +45 24 59 58 52
Mail: mia.lolk.lund@rsyd.dk
Sys Borcher Jørgensen
Phone: +45 23 63 17 96
Mail: sys.borcher.joergensen@rsyd.dk
Line Fuglsang Nielsen
Phone: +45 20 51 70 45
Mail: line.fuglsang.nielsen@rsyd.dk
David George Mawn
Phone: +45 29 16 50 83
Mail: david.mawn@rsyd.dk
Sussie Cordua Sørensen
Phone: +45 24 61 89 64
Mail: sussie.cordua.soerensen@rsyd.dk
Kamilla Dyrensborg-Nielsen
Phone.: +45 24 61 92 43
Mail: kamilla.dyrensborg-nielsen@rsyd.dk
Ole Aabling Sørensen
Phone: +45 23 63 17 86
Mail: ole.soerensen@rsyd.dk
Trine Madsen
Phone: +45 40 32 45 54
Mail: trine.madsen@rsyd.dk
Lene Fredsbo Jakobsen
Phone: +45 29 36 55 10
Mail: lene.jakobsen@rsyd.dk
Sanne Hee Stjerneholm
Phone: +45 29 36 55 13
Mail: sanne.hee.stjerneholm@rsyd.dk
Susanne Nørregaard
Phone: +45 20 58 58 70
Mail: susanne.noerregaard@rsyd.dk
Helle Houlbjerg Carlsen
Phone: +45 29 36 30 81
Mail: helle.houlbjerg.carlsen@rsyd.dk
Gitte Andersen
Phone: +45 21 84 92 84
Mail: gitte.andersen1@rsyd.dk
Anton Pottegård
Phone: +45 28 91 33 40
apottegaard@health.sdu.dk
Core Tasks
Sygehusapotek Fyn (SAF), the Hospital Pharmacy at Odense University Hospital (OUH), consists of the main pharmacy building located at OUH and a satellite department at OUH Svendborg Hospital. SAF also serves departments at the hospitals in Nyborg and Ærø as well as the Psychiatric Departments in Middelfart and Odense.
The hospital pharmacy provides:
Distribution of drugs.
Clinical pharmacy including medication review, medication history, medication reconciliation and medication discharge consultation
Services in relation to clinical trials (some regarding production of cytostatic drugs for the individual cancer patient)
Information about drugs and drug management
Production of drugs: "ready-to-use" and drugs produced especially for individual patients
The Danish National Stability Lab (DNSL)
Research
SAF also produces medication for other hospitals in Denmark, for instance in collaboration with other hospital pharmacies in Denmark.
On an ongoing basis, the focus area for most projects at the hospital pharmacy is preparing for Nyt OUH (the New Hospital Project) which is expected to be ready in 2022. The level of services and tasks delivered by SAF at Nyt OUH will be of a different nature than today with continuous focus on patient safety and ready-to-use medication. This requires preparation and changes towards the new tasks.
In 2017, SAF had a turnover of about 1.1bn DKK. The hospital pharmacy currently has about 250 employees within different professional background (pharmacists, engineers, laboratory technologists, chemists, technicians, pharmaconomists, pharmacy assistants
etc.)
Partners
http://www.amgros.dk/en
Research Areas
The research unit at Hospital Pharmacy Funen has existed for two years and currently includes 10 researchers (3 full time, 4 part time, and 3 externally affiliated). The
The research unit at Hospital Pharmacy Funen has existed for two years and currently includes 10 researchers (3 full time, 4 part time, and 3 externally affiliated). The
The research unit at Hospital Pharmacy Funen has existed for two years and currently includes 10 researchers (3 full time, 4 part time, and 3 externally affiliated). TheThe research unit at Hospital Pharmacy Funen has existed for two years and currently includes 10 researchers (3 full time, 4 part time, and 3 externally affiliated). TheThe research unit at Hospital Pharmacy Funen has existed for two years and currently includes 10 researchers (3 full time, 4 part time, and 3 externally affiliated). The unit focuses primarily on clinical research, mainly related to deprescribing and sector transitions.
Deprescribing
Deprescribing constitutes one of the research units two main research areas. The unit primarily works with deprescribing in older people at the end of life, pragmatically defined as frail older people with a life expectancy of 1-2 years, with the overall aim being to improve quality of life within this particular population.
The research unit engages with this topic through many different initiatives and with several different national and international collaborators from primary as well as secondary care. The unit has conducted three systematic reviews and two qualitative studies exploring different aspects of end of life deprescribing and is currently working on a questionnaire study, aiming to quantify Danish nursing home residents perceptions of and attitudes towards deprescribing. The results from these preliminary studies will form the basis of the development of a deprescribing tool for hospitalized frail older people (expected start in early 2019) which will ultimately be tested in a clinical trial (expected start in fall 2019). Further, the unit is currently preparing a feasibility study on deprescribing of acetaminophen in
nursing home residents which will be initiated in early 2019. Finally, the unit is also planning a nationwide randomized controlled trial on strategies for deprescribing of proton pump inhibitors.
Sector
The second main research area the research unit works in is sector transitions, aiming to ensure quality and safety in patients medication when they undergo the transition from secondary toprimary care following hospitalization.
The research unit is currently working on a project aimed at developing and testing a model in which clinical pharmacists and geriatric doctors conduct a telephone conference with general practitioners following discharge of geriatric patients. The goal with this project is to ensure the best transition from secondary to primary care regarding the patients medication and to enhance the dialogue between health care professionals from primary and secondary care. The project builds upon the results from another project recently conducted by the unit. In this large randomized controlled trial, it was found that an extended clinical pharmacist intervention, based upon medication review, motivational interviews, and follow-up with primary care, has the potential to reduce the number of hospital readmissions and emergency department visits.
If you are interested in learning more about the research units work or discussing the possibilities for future collaboration, please contact Head of Research Anton Pottegård (apottegaard@health.sdu.dk, +45 6550 3024).
Key figures
| 2017 Turnover | DKK 1.1 bn |
| 2017 Employees | 250 employees |
| Packages per year handled by the pharmacy stock department | 1.2 mio. packages |
| Percentage of departments at Odense University Hospital with medication distribution and stocking | 99% |
| Percentage of departments at Odense University Hospital with medication histories and reconciliation (pharmaconomist services) | 70% |
| 2017 Coupled antibiotics | 157000 units |
| 2017 Production/preparation of cytotoxic drugs | 57800 units |